Mipharma
Board
1 director, no change since 2022Mandates through the years
2 names, the dashed line is todayDirector
Manager
BoardEarlier
Mandates as a list
-
- Director, from 02-06-2022 to date
-
- Manager, from 29-09-2015 to 10-06-2022
Control
Founder
This company
Mipharma
Equity €267,638
Profit €39,091 in 2025
Capital
- Contribution
- €18,600
- Shares
- 186
- Contribution per share
- €100
- Equity per share
- €1,439 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 10-06-2022 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Bestuursorgaan, uitdrukkelijk akkoord bestuurde vennootschap”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Werkelijke waarde op dag overdracht, voorzitter bevoegde Ondernemingsrechtbank zitting houdend zoals in kort geding”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Thursday of December at 14:00
Founder
At incorporation
deed of 01-10-2015 ↗
- sole founder · 100% at incorporation
Capital transactions
Capital over time
- 10-06-2022 Converted to unavailable equity
- 01-10-2015 Incorporation · €18,600 · 186 shares